相似文献
1
Comment on: "Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease": Participant evaluation.
Pediatr Blood Cancer. 2025 Jan;72(1):e31382. doi: 10.1002/pbc.31382. Epub 2024 Oct 12.
2
Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease.
Pediatr Blood Cancer. 2024 Apr;71(4):e30878. doi: 10.1002/pbc.30878. Epub 2024 Feb 6.
3
HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol.
BMC Pediatr. 2019 Oct 15;19(1):354. doi: 10.1186/s12887-019-1746-6.
4
HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.
J Pediatr. 2018 Jun;197:177-185.e2. doi: 10.1016/j.jpeds.2018.01.054. Epub 2018 Mar 20.
5
Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.
Contemp Clin Trials. 2016 Jul;49:134-42. doi: 10.1016/j.cct.2016.06.004. Epub 2016 Jun 17.
6
Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: The HABIT study.
Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26689. Epub 2017 Jun 23.
7
Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill records.
Pediatr Blood Cancer. 2024 Sep;71(9):e31170. doi: 10.1002/pbc.31170. Epub 2024 Jul 8.
8
Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease.
Pediatr Blood Cancer. 2019 Jul;66(7):e27740. doi: 10.1002/pbc.27740. Epub 2019 Apr 2.
9
Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study.
JMIR Res Protoc. 2020 Jul 14;9(7):e16319. doi: 10.2196/16319.
10
Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID-19 pandemic.
Pediatr Blood Cancer. 2022 Sep;69(9):e29797. doi: 10.1002/pbc.29797. Epub 2022 May 25.
本文引用的文献
1
Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease.
Pediatr Blood Cancer. 2024 Apr;71(4):e30878. doi: 10.1002/pbc.30878. Epub 2024 Feb 6.
2
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Blood Adv. 2023 Dec 12;7(23):7190-7201. doi: 10.1182/bloodadvances.2023010670.
3
Community Health Worker Integration with and Effectiveness in Health Care and Public Health in the United States.
Annu Rev Public Health. 2023 Apr 3;44:363-381. doi: 10.1146/annurev-publhealth-071521-031648.
4
The Adoption and Acceptance of mHealth Interventions for Self-Management of Hypertension Among Adult Patients: A Systematic Review.
Cureus. 2022 Nov 16;14(11):e31584. doi: 10.7759/cureus.31584. eCollection 2022 Nov.
5
Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative.
Front Genet. 2022 Aug 26;13:921432. doi: 10.3389/fgene.2022.921432. eCollection 2022.
6
Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review.
Biomed Res Int. 2022 Jul 18;2022:2122056. doi: 10.1155/2022/2122056. eCollection 2022.
7
Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID-19 pandemic.
Pediatr Blood Cancer. 2022 Sep;69(9):e29797. doi: 10.1002/pbc.29797. Epub 2022 May 25.
8
A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
Br J Haematol. 2022 Jan;196(1):193-203. doi: 10.1111/bjh.17952. Epub 2021 Nov 16.
9
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
10
The Impact of Social Determinants of Health on Medication Adherence: a Systematic Review and Meta-analysis.
J Gen Intern Med. 2021 May;36(5):1359-1370. doi: 10.1007/s11606-020-06447-0. Epub 2021 Jan 29.
Zotero 插件